Elixi, Author at Elixi International - Page 4 of 13

7 June 2021

Wegovy (semaglutide) injection – first approved drug for chronic weight management since 2014

0 Comments5 Minutes

1 June 2021

Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C

0 Comments3 Minutes

3 May 2021

Farxiga (dapagliflozin) Approved for the treatment of Chronic Kidney Disease

0 Comments4 Minutes

27 April 2021

Enspryng (satralizumab), new treatment for rare autoimmune disease of nerve cells

0 Comments2 Minutes

17 April 2021

Novartis receives EU approval for Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for adult patients with relapsing multiple sclerosis

0 Comments3 Minutes

3 April 2021

Abecma (idecabtagene vicleucel), First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

0 Comments2 Minutes

23 March 2021

ARCALYST (rilonacept) is the first FDA-approved therapy for recurrent pericarditis

0 Comments3 Minutes

27 February 2021

Evrysdi (Risdiplam), First oral treatment for spinal muscular atrophy (SMA)

0 Comments3 Minutes

14 February 2021

Cosela (trilaciclib), first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression

0 Comments1 Minutes

9 February 2021

Breyanzi (lisocabtagene maraleucel), new Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma

0 Comments2 Minutes